Breast Cancer After Treatment of Hodgkin's Lymphoma: General Review

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1291-1297

  Alm El Din, Mohamed A ^a,b   El Badawy, Samy A ^c   Taghian, Alphonse G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TANTA UNIVERSITY HOSPITAL   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Breast Cancer; Hodgkin's lymphoma; review

Indexed keywords

AFTER TREATMENTS; BREAST CANCER; BREAST CANCERS; EARLY DETECTIONS; HODGKIN'S LYMPHOMA; HODGKIN'S LYMPHOMAS; OPTIMAL TIMES; SECOND MALIGNANCIES; SURVIVAL RATES;

POPULATION STATISTICS;

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

AGE DISTRIBUTION; BREAST CANCER; BREAST SELF EXAMINATION; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; ELECTRON THERAPY; FOLLOW UP; HODGKIN DISEASE; HUMAN; LONG TERM CARE; MAMMOGRAPHY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; SPLENECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BREAST NEOPLASMS; CHILD; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MECHLORETHAMINE; NEOPLASM STAGING; PREDNISONE; PROCARBAZINE; RADIOTHERAPY; RISK FACTORS; SPLENECTOMY; VINBLASTINE; VINCRISTINE; YOUNG ADULT;

EID: 56349153167     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.060     Document Type: Review

References (71)

1. Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Medico-Chirugical Trans 17 (1832) 68-114
2. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
3. Boivin J.F., and O'Brien K. Solid cancer risk after treatment of Hodgkin's disease. Cancer 61 (1988) 2541-2546
4. Kaldor J.M., Day N.E., Band P., et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 39 (1987) 571-585
5. Tucker M.A., Coleman C.N., Cox R.S., et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318 (1988) 76-81
6. Wahner-Roedler D.L., Nelson D.F., Croghan I.T., et al. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. Mayo Clin Proc 78 (2003) 708-715
7. Devita Jr. V.T., Serpick A.A., and Carbone P.P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73 (1970) 881-895
8. Bonadonna G., Zucali R., Monfardini S., et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36 (1975) 252-259
9. Wirth A., Corry J., Laidlaw C., et al. Salvage radiotherapy for Hodgkin's disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 39 (1997) 599-607
10. Somers R., Carde P., Henry-Amar M., et al. A randomized study in Stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: A European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial. J Clin Oncol 12 (1994) 279-287
11. Meyer R.M. Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?. Eur J Haematol Suppl (2005) 115-120
12. Kaplan H. Hodgkin's disease. Vol 2 (1980), Harvard University Press, Cambridge, MA
13. Meyer R.M., Gospodarowicz M.K., Connors J.M., et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol 23 (2005) 4634-4642
14. Diehl V. Hodgkin's disease-from pathology specimen to cure. N Engl J Med 357 (2007) 1968-1971
15. Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 (2007) 579-586
16. Diehl V., Franklin J., Pfreundschuh M., et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348 (2003) 2386-2395
17. Raemaekers J., Burgers M., Henry-Amar M., et al. Patients with Stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: Interim results from the ongoing EORTC-LCG and GPMC Phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie. Ann Oncol 8 Suppl 1 (1997) 111-114
18. Aleman B.M., Raemaekers J.M., Tirelli U., et al. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 348 (2003) 2396-2406
19. Hancock S.L., Tucker M.A., and Hoppe R.T. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85 (1993) 25-31
20. Bhatia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334 (1996) 745-751
21. Sankila R., Garwicz S., Olsen J.H., et al. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 14 (1996) 1442-1446
22. Tinger A., Wasserman T.H., Klein E.E., et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 37 (1997) 865-870
23. van Leeuwen F.E., Klokman W.J., Hagenbeek A., et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12 (1994) 312-325
24. Wolden S.L., Lamborn K.R., Cleary S.F., et al. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16 (1998) 536-544
25. Gervais-Fagnou D.D., Girouard C., Laperriere N., et al. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology 57 (1999) 224-231
26. Alm El-Din M.A., Hughes K.S., Finkelstein D.M., et al. Breast cancer after treatment of hodgkin's lymphoma: Risk factors that really matter. In press. Int J Radiat Oncol Biol Phys (2008)
27. Metayer C., Lynch C.F., Clarke E.A., et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18 (2000) 2435-2443
28. Ng A.K., Bernardo M.V., Weller E., et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 100 (2002) 1989-1996
29. Travis L.B., Curtis R.E., and Boice Jr. J.D. Late effects of treatment for childhood Hodgkin's disease. N Engl J Med 335 (1996) 352-353
30. Travis L.B., Hill D., Dores G.M., et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97 (2005) 1428-1437
31. van Leeuwen F.E., Klokman W.J., Veer M.B., et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18 (2000) 487-497
32. Kaldor J.M., Day N.E., Clarke E.A., et al. Leukemia following Hodgkin's disease. N Engl J Med 322 (1990) 7-13
33. Travis L.B., Hill D.A., Dores G.M., et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290 (2003) 465-475
34. Baral N.E., Larsson L.E., and Mattsson B. Breast cancer following irradiation of the breast. Cancer 40 (1977) 2905-2910
35. Boice Jr. J.D. Radiation and breast carcinogenesis. Med Pediatr Oncol 36 (2001) 508-513
36. Boice Jr. J.D., Preston D., Davis F.G., et al. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 125 (1991) 214-222
37. Hildreth N.G., Shore R.E., and Dvoretsky P.M. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321 (1989) 1281-1284
38. Little M.P., and Boice Jr. J.D. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 151 (1999) 218-224
39. Mattsson A., Ruden B.I., Hall P., et al. Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 85 (1993) 1679-1685
40. Preston D.L., Mattsson A., Holmberg E., et al. Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat Res 158 (2002) 220-235
41. Zellmer D.L., Wilson J.F., and Janjan N.A. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 1343-1351
42. van Leeuwen F.E., Klokman W.J., Stovall M., et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95 (2003) 971-980
43. Koh E.S., Tran T.H., Heydarian M., et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk. Radiat Oncol 2 (2007) 13
44. Salloum E., Doria R., Schubert W., et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 14 (1996) 2435-2443
45. Chung C.T., Bogart J.A., Adams J.F., et al. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 37 (1997) 405-409
46. Dietrich P.Y., Henry-Amar M., Cosset J.M., et al. Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen?. Blood 84 (1994) 1209-1215
47. Alm El-Din MA, Hughes KS, Abi Raad R, et al. Breast cancer occurring after treatment for Hodgkin's lymphoma: Case-control analysis. Submitted for publication.
48. Dershaw D.D., Yahalom J., and Petrek J.A. Breast carcinoma in women previously treated for Hodgkin disease: Mammographic evaluation. Radiology 184 (1992) 421-423
49. Wolden S.L., Hancock S.L., Carlson R.W., et al. Management of breast cancer after Hodgkin's disease. J Clin Oncol 18 (2000) 765-772
50. Yahalom J., Petrek J.A., Biddinger P.W., et al. Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10 (1992) 1674-1681
51. Cutuli B., Dhermain F., Borel C., et al. Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer 33 (1997) 2315-2320
52. Tokunaga M., Land C.E., Tokuoka S., et al. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 138 (1994) 209-223
53. Nyandoto P., Muhonen T., and Joensuu H. Second cancer among long-term survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 42 (1998) 373-378
54. National Cancer Institute. Surveillance Epidemiology and End Results. SEARCH Cancer Statistics review. Available at: http://seer.cancer.gov/cgi-bin/csr/1975_2004/search.pl#results. Accessed October 16, 2008.
55. Heron D.E., Komarnicky L.T., Hyslop T., et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 88 (2000) 2739-2750
56. Hungness E.S., Safa M., Shaughnessy E.A., et al. Bilateral synchronous breast cancer: Mode of detection and comparison of histologic features between the 2 breasts. Surgery 128 (2000) 702-707
57. Janov A.J., Tulecke M., O'Neill A., et al. Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study. Breast J 7 (2001) 46-52
58. Mauch P.M., Kalish L.A., Marcus K.C., et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87 (1996) 3625-3632
59. Christie D.R., Wills R., Drew J.F., et al. The doses received by the breast during mantle radiotherapy. Int J Radiat Oncol Biol Phys 41 (1998) 223-226
60. Valagussa P. Second neoplasms following treatment of Hodgkin's disease. Curr Opin Oncol 5 (1993) 805-811
61. Sanna G., Lorizzo K., Rotmensz N., et al. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors. Ann Oncol 18 (2007) 288-292
62. Aref I., and Cross P. Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease. Br J Radiol 73 (2000) 905-906
63. Deutsch M., Gerszten K., Bloomer W.D., et al. Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma. Am J Clin Oncol 24 (2001) 33-34
64. Intra M., Gentilini O., Veronesi P., et al. A new option for early breast cancer patients previously irradiated for Hodgkin's disease: Intraoperative radiotherapy with electrons (ELIOT). Breast Cancer Res 7 (2005) R828-R832
65. Alm El-Din M.A., Feng J.K., and Taghian A.G. Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma. Nat Clin Pract Oncol 5 (2008) 426-429
66. Diller L., Medeiros Nancarrow C., Shaffer K., et al. Breast cancer screening in women previously treated for Hodgkin's disease: A prospective cohort study. J Clin Oncol 20 (2002) 2085-2091
67. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis Guidelines V.I. 2008. Available at: http://www.nccn.org/professionals/physician_gls/PDF/breast-screening.pdf. Accessed May 29, 2008.
68. Berg W.A., Blume J.D., Cormack J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299 (2008) 2151-2163
69. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 (2007) 75-89
70. Aisenberg A.C., Finkelstein D.M., Doppke K.P., et al. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79 (1997) 1203-1210
71. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90 (1998) 1371-1388